Maria Rosaria Raspollini

Snowy and busy weekend in Brussels for ExCo and Counsil Meetings #ESP #pathology #❤️

🌍🔬 We were honored to welcome participants from more than 20 countries across the globe, reflecting the truly international reach of our society. With sincere gratitude to all who contributed, we look forward to seeing you again next year in Stockholm at the 2026 ECP. #gupath

I usually refrain from sharing personal achievements but this one is too special, being a keynote lecturship named after one of my most iconic mentors Dr. Juan Rosai @ESP_Pathology European Society of Pathology congress 2025 @TheUSCAP @PennPathLabMed @PennMedicine @ASCP_Chicago @ASCO

🎇What a week! What a Congress! What a #pathology Community!🎆 We conclude this year's #ESPCongress with new record numbers! We are humbled with the engagement of the Community, wish all a safe return, and looking forward to seeing you in 2026 in Stockholm! #PathTwitter #PathX

The @IntSocUropath #ISUP Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in #Prostate and #Bladder Cancer at the elegant Josephinum Vienna. The meeting was a success with consensus reached in majority of statements. Congratulations all! #GUPath

🏆ESP is proud to join @ESGO_society and @ESTRO_RT in generating the updated guidelines for management of patients with Endometrial Carcinoma! 🧬🔬🔍 🎙️You may read the joined press release here: esp-pathology.org/wp-content/upl… 📰The paper is available here: thelancet.com/journals/lanoc…

Just published in The Lancet! ‼️🗞️ ESGO-ESTRO-ESP Guidelines for the Management of Patients with Endometrial Carcinoma: 2025 Update These guidelines are an update from the prior guidelines published in 2021 and cover all relevant aspects of diagnosis, management, follow-up & patient education. They consider the large body of new evidence in this field & incorporate the 2023 FIGO update, which reflects the improved understanding of the complex nature of the different types of endometrial carcinoma & their underlying biological behaviour. Read the paper 👉 thelancet.com/journals/lanoc… Read our press release about this important update 👉 esgo.org Watch our series of webinars about this update 👉 eacademy.esgo.org #gynonc #oncoalert @estro_rt @esp_pathology

@ESGO_society Just published!!!

Path to Fight Cancer #FightCancer #Pathology

🗣️ Si è tenuto nei giorni scorsi il primo corso organizzato dal GOM Tumori Area Urologica dell’Azienda Careggi, dedicato al “Ruolo del Gruppo Oncologico Multidisciplinare nella gestione del paziente con carcinoma renale: Focus sulla terapia adiuvante”.  #Careggi #Urologia

Are you in Boston, MA for #USCAP25? Then drop by at the ESP booth (No. 1013) to chat with us! We will be happy to inform about 🔷the benefits of ESP membership 🔷The #ESPCongress in Vienna 🔷our many, onsite and online, educational activities! 🔷our EQA programmes! #PathTwitter

Joint Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP) Expert Consultation on Intraductal Carcinoma of the Prostate. Two great societies working together towards a common goal. I’m honored to be in this event. #GUPath #I❤️pathology

Expert Consultation Conference on Intraductal Carcinoma of the Prostate #pathologists #prostate #GUPS #ISUP #Boston2025 GUPS and ISUP have jointly organized. An Expert Consultation Conference to address the issue and controversies on IDC-P

🔬 A busy day for #pathologists performing fine-needle aspiration! This thyroid nodule is particularly challenging… and I 💕 challenges! Catarina Eloy, Pathologist at IPATIMUP, Porto, Portugal, Chair of the Education subcommittee of ESP #EveryDayPathology #PathTwitter

1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tumor immunity in high-risk renal cell carcinoma”. A trial of #RCC vaccine, led together with first author @BraunMDPhD @YaleCancer and #PatrickOtt #DerinKeskin #CatherineWu @DanaFarber nature.com/articles/s4158… @DanaFarber_GU @OncoAlert @DFCI_NeoVax

🔬 Daily pathology in action! Discussing a challenging gynaecologic tumour case with Dr Gatius, ESP alumni. Integrating morphology & molecular data is key to precision diagnosis. Dr Xavier Matias-Guiu, President-elect of ESP, Spain. #EveryDayPathology #PathTwitter

Great Initiative from the @ESP_Pathology and a great starting post!

ESP would like to wish to all, the very best for the Holiday Season and for the New Year to bring the best to you and your loved ones! #PathTwitter #PathX

@daniel_berney @xmatiasguiu @ESP_Pathology We should change this wrong way….

@ro36693000 @xmatiasguiu @ESP_Pathology 👏🏻👏🏻sadly what usually happens is we are left sweeping up the mess left over after the trial has started….

The role of pathologist in the design and conducting of biomarker-driven trials in cancer: position paper of the European Society of Pathology @xmatiasguiu @ESP_Pathology